What Legal Claims Can Arise from Deceptive Advertising Litigation?

Under the Lanham Act, Section 43(a), a plaintiff must establish that the defendant made a false or misleading statement of fact in commercial advertising, that the statement is material to purchasing decisions, that the plaintiff suffered injury as a result, and that the defendant's conduct caused that injury. Unlike fraud, Lanham Act claims do not require proof of scienter or intent to deceive; materiality is often presumed for certain categories of claims (such as statements about product efficacy or price). Courts apply a multi-factor test to assess whether a reasonable consumer would be deceived by the advertisement, considering context, overall net impression, and the sophistication of the target audience.

State consumer protection statutes create parallel private rights of action and often allow recovery of statutory damages, attorney fees, and injunctive relief. Many states, including New York, define deceptive practices broadly to include any representation that is likely to mislead a reasonable consumer. State statutes may impose a lower burden of proof than common law fraud because they do not require reliance by each consumer or proof of scienter; instead, a plaintiff must show only that the practice was deceptive and caused injury. This creates a strategic advantage for plaintiffs in state court, as procedural defenses available in fraud cases (such as heightened pleading standards or reliance-on-individual-statements requirements) may not apply with equal force to statutory claims.

Materiality is the linchpin of most advertising claims because it bridges the gap between a false statement and actual harm. Courts examine whether the statement relates to a central quality or characteristic of the product, affects purchasing decisions, and is not merely peripheral or puffery. Puffery, such as vague superiority claims ("the best" or "premium quality"), is generally not actionable because reasonable consumers understand such statements as opinion rather than fact. By contrast, specific factual assertions about product composition, health benefits, environmental certifications, or comparative performance are typically deemed material as a matter of law or fact. In New York state court, a plaintiff alleging deceptive advertising must plead materiality with particularity if challenging a defendant's motion to dismiss, and delays in raising materiality evidence or loss documentation can create timing risks in summary judgment practice.

Common law fraud requires the plaintiff to prove each element by clear and convincing evidence: a false statement of material fact, scienter (knowledge of falsity or reckless disregard for truth), justifiable reliance by the plaintiff on that statement, and damages proximately caused by the reliance. Statutory deceptive practice claims, by contrast, typically require only a preponderance of evidence and do not require proof of scienter or individualized reliance; instead, the plaintiff must show that the practice was likely to deceive a reasonable consumer and caused injury to the plaintiff's business or the consumer class. This distinction creates a strategic advantage for plaintiffs in state-law claims and a corresponding defense opportunity for corporate defendants to challenge fraud claims on scienter or reliance grounds while defending statutory claims on materiality or causation theories.

Damages in Lanham Act and state consumer protection cases are calculated using multiple methodologies: lost profits (the difference between actual sales and hypothetical sales absent the deceptive practice), unjust enrichment (defendant's profits attributable to the deceptive conduct), corrective advertising costs (expenses to counteract the false message), or statutory damages under state law (fixed amounts per violation or per consumer affected). Plaintiffs bear the burden of proving causation between the deceptive statement and lost sales or profits, often through econometric analysis, market studies, or consumer surveys. Corporate defendants frequently challenge damages calculations at the summary judgment stage by arguing insufficient causation evidence or speculative profit projections.

Corporate defendants may assert that statements are puffery or opinion, not actionable fact; that the plaintiff failed to prove materiality, reliance, or causation; that the advertising complies with applicable regulatory standards or safe harbor provisions; or that the plaintiff lacks standing or suffered no injury. Procedurally, defendants often move to dismiss for failure to state a claim or move for summary judgment on materiality or causation grounds. Defendants may also argue that corrective advertising is the appropriate remedy rather than damages, or that the defendant's good-faith compliance with regulatory guidance (such as FTC endorsement guides or substantiation requirements) defeats liability. In some cases, defendants settle by agreeing to modify advertising language, provide consumer refunds, or fund corrective campaigns rather than proceed to trial.

The FTC requires that advertisers possess competent and reliable scientific evidence substantiating all objective claims about product performance, health benefits, or comparative superiority before making such claims. This substantiation standard applies regardless of whether the advertiser created the evidence or relied on third-party studies. Compliance requires documented review of studies, expert consultation, and clear labeling of limitations or disclaimers. Companies that fail to substantiate claims face FTC enforcement actions, consent decrees requiring corrective advertising, and private litigation under state consumer protection statutes. By contrast, companies that maintain substantiation files, conduct internal claim review, and document their compliance process strengthen their defense posture in advertising litigation and reduce the likelihood of regulatory referral.

Early case assessment should focus on the specificity of the challenged claim, the availability of substantiation or regulatory compliance evidence, and the plaintiff's proof of causation and damages. Defendants should promptly preserve all advertising materials, internal communications regarding claim development, consumer feedback, sales data, and market studies. Consider whether settlement through corrective advertising or claim modification is more cost-effective than protracted litigation, and evaluate insurance coverage for defense costs and potential liability. Engage counsel experienced in advertising litigation early to assess pleading vulnerabilities, motion practice opportunities, and discovery strategy. Document the company's compliance efforts, substantiation review process, and good-faith basis for marketing claims to support summary judgment motions and settlement negotiations.